Clinical Trial Applications: Filter, Search, and view applications
# | Protocol No | Study Title | Investigator(s) & Site(s) | |
---|---|---|---|---|
396. |
ECCT/23/05/02 | A5384 A Phase II, Randomized, Open-Label Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents with Tuberculous Meningitis: Improved Management with Antimicrobial AGents Isoniazid rifampiciN LinEzolid for TBM (IMAGINE-TBM) |
Principal Investigator(s) 1. Abraham Siika Site(s) in Kenya 1. Moi University Clinical Research Centre (Uasin Gishu county) 2. KEMRI Walter Reed Project (Kericho county) |
View |
397. |
ECCT/23/05/03 | BrainCapture EEG Validation Usability and efficacy of an affordable, smartphone-connected EEG device to bridge the global gap in epilepsy diagnosis |
Principal Investigator(s) 1. Diraj Sokhi Sokhi Site(s) in Kenya Aga Khan University Hospital Nairobi |
View |
398. |
ECCT/23/05/04 | PRIORITY Trial Prevention of Iron Deficiency Anemia Post-delivery |
Principal Investigator(s) 1. FABIAN OMODING ESAMAI 2. PAUL OBANDA NYONGESA Site(s) in Kenya BUSIA COUNTY REFERRAL HOSPITAL |
View |
399. |
ECCT/23/05/06 | Sildenafil citrate to improve Sildenafil citrate to improve maternal and neonatal outcomes in low-resource settings: a randomized feasibility trial |
Principal Investigator(s) 1. Nora Switchenko Site(s) in Kenya NAKURU COUNTY REFERRAL AND TEACHING HOSPITAL |
View |
400. |
ECCT/23/05/07 | LATA Long-Acting Treatment in Adolescents (LATA) A randomised open-label 2-arm 96 week trial in virologically suppressed HIV-1-positive adolescents aged 12-19 years of age in Sub-Saharan Africa |
Principal Investigator(s) 1. Abraham Siika Site(s) in Kenya 1. |
View |